Shareholders Meetings

Share capital and voting rights*

  • Share capital: €5,034 582.90
  • Number of shares outstanding: 100,691,658
  • Total number of voting rights: 106,134,467

*As of May 31, 2026

26
Jun 2025
15:46 E.S.T.

Vote results – AGM June 26, 2025

Download the PDF file
5
Jun 2025
09:55 E.S.T.

Cellectis Board of Directors members – Combined Shareholders Meeting – June 26, 2025

Download the PDF file
4
Jun 2025
13:25 E.S.T.

Voting Form – Combined Shareholders Meeting – June 26, 2025

Download the PDF file
4
Jun 2025
13:23 E.S.T.

Information regarding the director nominee Don BERGSTROM – Combined Shareholders Meeting – June 26, 2025

Download the PDF file
4
Jun 2025
13:20 E.S.T.

Brochure – Combined Shareholders Meeting – June 26, 2025

Download the PDF file
4
Jun 2025
13:20 E.S.T.

Information regarding the director nominee André MULLER – Combined Shareholders Meeting – June 26, 2025

Download the PDF file
21
May 2025
20:30 E.S.T.

Notice of Meeting – Combined General Meeting of Shareholders – June 26, 2025

Download the PDF file
21
May 2025
20:30 E.S.T.

Report of the board of directors to the Combined Shareholders’ Meeting – June 26, 2025

Download the PDF file

Get updates

Get the latest on gene-editing innovation, financial and business news from Cellectis with our email alert service.

Subscribe now